Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
JCI Insight|October 14, 2016
Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia modelsJoshua I Siner, Benjamin J Samelson-Jones, Julie M Crudele, et al.
Transfusion|January 9, 2007
A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newbornsVagner Castro, Hartmut Kroll, Andréa F Origa, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 1, 1991
Possible oral transmission of acute Chagas' disease in BrazilM A Shikanai-Yasuda, C B Marcondes, L A Guedes, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
Thrombosis and Haemostasis|May 6, 1998
Geographic distribution of the 20210 G to A prothrombin variantF R Rosendaal, C J Doggen, A Zivelin, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
American Journal of Hematology|September 25, 2004
Genetic variability of platelet glycoprotein Ibalpha geneMargareth C Ozelo, Devanira S P Costa, Lucia H Siqueira, et al.
Blood|September 21, 2010
In vivo efficacy of platelet-delivered, high specific activity factor VIII variantsTeshell K Greene, Cheng Wang, Jessica D Hirsch, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
JCI Insight|October 14, 2016
Circumventing furin enhances factor VIII biological activity and ameliorates bleeding phenotypes in hemophilia modelsJoshua I Siner, Benjamin J Samelson-Jones, Julie M Crudele, et al.
Transfusion|January 9, 2007
A prospective study on the prevalence and risk factors for neonatal thrombocytopenia and platelet alloimmunization among 9332 unselected Brazilian newbornsVagner Castro, Hartmut Kroll, Andréa F Origa, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|September 1, 1991
Possible oral transmission of acute Chagas' disease in BrazilM A Shikanai-Yasuda, C B Marcondes, L A Guedes, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2023
Analysis of vector genome integrations in multicentric lymphoma after AAV gene therapy in a severe hemophilia A dogLucas Van Gorder, Bhavya S Doshi, Elinor Willis, et al.
Thrombosis and Haemostasis|May 6, 1998
Geographic distribution of the 20210 G to A prothrombin variantF R Rosendaal, C J Doggen, A Zivelin, et al.
Blood|September 30, 2010
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyJonathan D Finn, Margareth C Ozelo, Denise E Sabatino, et al.
Blood|July 5, 2007
Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liverFederico Mingozzi, Nicole C Hasbrouck, Etiena Basner-Tschakarjan, et al.
American Journal of Hematology|September 25, 2004
Genetic variability of platelet glycoprotein Ibalpha geneMargareth C Ozelo, Devanira S P Costa, Lucia H Siqueira, et al.
Blood|September 21, 2010
In vivo efficacy of platelet-delivered, high specific activity factor VIII variantsTeshell K Greene, Cheng Wang, Jessica D Hirsch, et al.
Nature Biotechnology|October 25, 2011
A zymogen-like factor Xa variant corrects the coagulation defect in hemophiliaLacramioara Ivanciu, Raffaella Toso, Paris Margaritis, et al.
Pageof 19